Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CYNK-101 |
Synonyms | |
Therapy Description |
CYNK-101 consists of CD34+ human placental-derived allogeneic NK cells engineered to express a modified version of CD16, potentially resulting in antibody-dependent cellular cytotoxicity against tumor cells (Blood 2020; 136 (Supplement 1):1). |